Mainz Biomed B.V.
Mainz Biomed B.V. (MYNZ) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001874252 · MYNZ · NASDAQ · as of Jun 10, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001874252 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Mainz Biomed B.V. (NASDAQ: MYNZ) has submitted 172 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001874252, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Mainz Biomed B.V.'s most comprehensive regulatory disclosure. The most recent Mainz Biomed B.V. 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical MYNZ 10-K annual reports are available from 2021 through 2026.
Investors researching Mainz Biomed B.V. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
MYNZ SEC Filings · 8 questionsMainz Biomed B.V. (MYNZ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 172 filings and access original documents at no cost. Mainz Biomed B.V.'s CIK is 0001874252.